Labeling and Diagnostic Value of miRNA-28-3p in Patients with Nasopharyngeal Carcinoma
View abstract on PubMed
Summary
This summary is machine-generated.MicroRNA-28-3p is overexpressed in nasopharyngeal carcinoma (NPC), inhibiting tumor growth and metastasis by targeting BIN1. Its expression levels are a sensitive indicator for NPC prediction.
Area Of Science
- Oncology
- Molecular Biology
- Biomarker Discovery
Background
- Nasopharyngeal carcinoma (NPC) is a significant health concern.
- Understanding the molecular mechanisms underlying NPC progression is crucial for developing effective diagnostic and therapeutic strategies.
Purpose Of The Study
- To investigate the role of microRNA-28-3p (miRNA-28-3p) in nasopharyngeal carcinoma (NPC).
- To determine if miRNA-28-3p targets BIN1 and influences NPC cell behavior.
- To evaluate miRNA-28-3p as a potential predictive biomarker for NPC.
Main Methods
- Analysis of miRNA-28-3p and BIN1 expression in NPC tissues and cell lines.
- Utilizing techniques such as PCR, Western blotting, CCK-8, and flow cytometry.
- Investigating the functional impact of miRNA-28-3p inhibition on NPC cell proliferation, apoptosis, invasion, and migration.
Main Results
- miRNA-28-3p was significantly upregulated in NPC tissues and cells compared to normal controls.
- miRNA-28-3p expression demonstrated a predictive performance for NPC with an AUC > 0.75.
- Inhibition of miRNA-28-3p led to increased apoptosis and BIN1 protein levels, while decreasing proliferation, invasion, and migration.
Conclusions
- miRNA-28-3p is overexpressed in NPC and acts as a tumor suppressor by targeting BIN1, inhibiting proliferation, migration, and invasion, while promoting apoptosis.
- miRNA-28-3p expression levels are a sensitive biomarker for NPC prediction.
- These findings highlight miRNA-28-3p's potential as a diagnostic biomarker and therapeutic target for NPC.

